Trailing-twelve-month (TTM) revenue is $5.79 Million with a year-over-year growth of (15.22%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,966,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $1,482,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-25 |
| Q1 FY2026Period ended 2026-03-31 | $888,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $1,453,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-11 |
| TTM revenue | $5,789,000 |
Current P/S: $16,030,084 market capitalization ÷ $5,789,000 TTM revenue = 2.77x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:33:40.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.45M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:36:56.461Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD |
|---|---|
| Consulting Revenues | $4M |
$5.79M
$5.79 Million
(15.22%)
vs. $6.83M a year ago (TTM)
+1.40%
5 Year compound annual growth rate
1 Year
(15.22%)
3 Year
+0.64%
5 Year
+1.40%
10 Year
(0.59%)
15 Year
+1.51%
20 Year
+0.60%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $7.09M | +$1.32M | +22.94% |
| 2024 | $5.77M | +$160,000 | +2.85% |
| 2023 | $5.61M | ($1.92M) | (25.47%) |
| 2022 | $7.53M | +$252,000 | +3.46% |
| 2021 | $7.28M | +$658,000 | +9.94% |
| 2020 |
TTM Growth
(15.22%)
3-Year CAGR
+0.64%
5-Year CAGR
+1.40%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:36:56.461Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $6.62M |
| ($7.02M) |
| (51.48%) |
| 2019 | $13.64M | +$3.37M | +32.77% |
| 2018 | $10.28M | +$3.41M | +49.75% |
| 2017 | $6.86M | +$760,000 | +12.45% |
| 2016 | $6.10M | ($722,000) | (10.58%) |
